Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study-Reference-Cited by-同舟云学术

Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

Published:2018-03-28 Issue:2 Volume:108 Page:192-198
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Morimoto Akira^ORCID, ,Shioda Yoko,Imamura Toshihiko,Kudo Kazuko,Kitoh Toshiyuki,Kawaguchi Hiroshi,Goto Hiroaki,Kosaka Yoshiyuki,Tsunematsu Yukiko,Imashuku Shinsaku

Funder

the Ministry of Health, Labor, and Welfare, Japan

the Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/s12185-018-2444-0/fulltext.html

Reference23 articles.

1. Morimoto A, Oh Y, Shioda Y, Kudo K, Imamura T. Recent advances in Langerhans cell histiocytosis. Pediatr Int. 2014;56:451–61.

2. Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to histiocytosis X? Br J Haematol. 2015;169:3–13.